St. Jude Medical and Thoratec Announce Definitive Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Fed’s Waller open to September rate hold—if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Wells Fargo Downgrades Thoratec (THOR) to Market Perform
July 23, 2015 7:12 AM EDTWells Fargo downgraded Thoratec (NASDAQ: THOR) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Thoratec click here. For more ratings news on Thoratec click here.
Shares of Thoratec closed at $63.46 yesterday.
... MoreSt. Jude Medical (STJ) PT Raised to $80 at Evercore ISI on Thoratec Accretion
July 22, 2015 1:57 PM EDTEvercore ISI analyst Vijay Kumar raised estimates and his price target on St. Jude Medical (NYSE: STJ) to $80.00 (from $77.50) following the acquisition of Thoratec (NASDAQ: THOR) but maintained a Hold rating.
Kumar commented, "STJ's quarterly results took a backseat with investors mainly focused on the announcement of acquisition of Thoratec, a leading LVAD (left ventricular assist device) player for Class IV heart failure patients. Strategically the acquisition makes sense for STJ, given its... More
Thoratec (THOR) Prelim. Q2 Revenue Tops Expectations
July 22, 2015 7:06 AM EDTThoratec (NASDAQ: THOR) announced preliminary unaudited revenue in the range of $128 million to $129 million for the second quarter of 2015.
*** The Street was looking for revenue of $115.5 million.
"Our strong second quarter performance resulted from a broad increase in utilization of our... More
